|Day Low/High||58.46 / 59.87|
|52 Wk Low/High||52.04 / 77.03|
New rapid tests and the effectiveness of universal mask wearing give hope while we wait on the elusive vaccine.
Neither candidate seems to be the enemy of the market -- at least not yet.
Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.
Follow fundamentals and ignore the attempts to gaslight you into not believing your own projections.
CVS has strong fundamentals, a good price, and plenty of room to catch up.
CVS is an undervalued health care stock with a solid dividend yield above 3%.
It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.
Why aren't we figuring out how to cure the test bottleneck?
Even the president has switched sides on this issue that could help flatten the curve and help get the economy rolling again.
If you are long CVS continue to hold.
Let's go over five excuses so you know and are armed with them when they are used and make you faint and weak-handed.
The RMPIA rebounded more than 22% in the June quarter to finish up 7.8% at the 2020 half mark.
The Federal Reserve posted its June meeting minutes and a report on individual corporate bonds bought so far. Here's my take on both.
I would wait until the next down day, and there will be one.
Here's how to play CVS Health and avoid most negative investing side effects.
After CVS released quarterly earnings and the CEO's appearance on 'Mad Money,' let's look at the charts for this health and pharmacy retailer.
CVS Health states that the chain has kept its stores open as an 'essential' retailer through this pandemic.
Disney's trajectory could provide a blueprint for the reopening of travel and leisure -- and how investors react.
The charts of CVS are in good shape, so expect renewed strength in the weeks ahead.
Some businesses offer curbside delivery while others boost online sales -- still some can't escape closings and cut forecasts.
Let's check and see if all their programs and initiatives could help the charts and indicators of CVS.
As I've stated before, I'm looking for names that are 'stupid cheap', and I'm not sure we're there yet.
It's online, off-price, or nothing in the time of the coronavirus.
Here are a number of things that I'm watching now.
With so many consumers preparing for a potential coronavirus outbreak, you might think that owning retail pharmacy stocks makes sense right now.